My Cancer Advisor > Latest Cancer News

Latest Cancer News

Top Headliners

  1. New Drug Approved for the Most Aggressive Form of Melanoma

  2. Big Beer Drinkers at Big Risk for Stomach Cancer

  3. FDA Approves Innovative Device for Brain Cancer Treatment

  4. Some With Breast Cancer May Be Able to Skip Full Lymph Node Removal

  5. Study of Breast Biopsies Finds Surgery Used Too Extensively

______________________________________________________________

RSS Feeds

News and Features from the American Cancer Society

Google Cancer News

  • This RSS feed URL is deprecated, please update. New URLs can be found in the footers at https://news.google.com/news
  • Pfizer's Bet On Oncology
    Forbes
    Pfizer's Oncology segment accounts for less than 20% of the company's value, according to our estimates. For many other major pharma companies, their oncology portfolios are larger contributors to their top lines, and Pfizer has been looking to ...

  • Forbes
  • In Brief This Week: Abbott, Strata Oncology, Premaitha, Science ...
    GenomeWeb
    NEW YORK (GenomeWeb) – Abbott's board increased its quarterly common dividend to $.28 from $.265 per share, payable Feb. 15, 2018 to shareholders of record as of the close of the business day on Jan. 12, 2018. Strata Oncology said this week that five ...
  • Anticipating fundamental change in oncology
    The Cancer Letter Publications
    In 2017, The Cancer Letter's readership grew by over 40 percent and the number of page views has nearly doubled from the 2016 level. On an average day in 2017, our website got over 1,700 visits and over 12,500 page views. By way of comparison, in 2016 ...

  • Endpoints News
  • These Two Oncology Drugs Are Key To Roche's Future Growth
    Forbes
    Roche's Oncology business accounts for over 50% of the company valuation, according to our estimates. The company's blockbuster oncology drugs are Avastin, Herceptin and MabThera/Rituxan, as these three drugs alone accounted for roughly 40% of the ...

  • Targeted Oncology
  • Belleville Intelligencer
  • Seeking Alpha
  • Average Profit Margin on Oncology Drugs For 340B Hospitals Nears 50%
    AJMC.com Managed Markets Network
    "The Oncology Drug Marketplace: Trends in Discounting and Site of Care," commissioned by the Community Onoclogy Alliance and conducted by Berkley Research Group, found that 340B hospitals have a clear financial incentive to expand oncology services ...

Cancer News from MSNBC
Error: It's not possible to reach RSS file...

Ipilimumab Approved for Melanoma